Austrian Biotech Database

News in the Life Sciences Industry
Results 21 - 40 out of 98 displayed.
« 1 2 3 4 5 »

Valneva Completes Delisting from the Vienna Stock Exchange

By: GlobenewsWire - 20 Dec 2019

Qu Biologics Completes Enrollment in First Stage of Phase 2 Clinical Trial in Moderate to Severe Crohn’s Disease

By: GlobenewsWire - 18 Dec 2019

CMT's Manufacturing Automation Asia Summit draws Automotive, Aerospace, Pharma, Electronics, Chemical Manufacturers to Singapore

SINGAPORE, Dec. 17, 2019 /PRNewswire/ -- Manufacturing Automation Asia organized by Centre for Management Technology (CMT) will be held in advanced manufacturing hub - Singapore, the summit brings together key insights from manufacturers who have already adopted Read more ››

By: PR Newswire Association LLC. - 17 Dec 2019

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 16 Dec 2019

Valneva Appoints MVM Partner Thomas Casdagli to its Supervisory Board

By: GlobenewsWire - 12 Dec 2019

Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease

By: GlobenewsWire - 10 Dec 2019

Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)

By: GlobenewsWire - 10 Dec 2019

Sanofi CEO unveils new strategy to drive innovation and growth

By: GlobenewsWire - 09 Dec 2019

Novo Nordisk A/S – Share repurchase programme

By: GlobenewsWire - 09 Dec 2019

Valneva Appoints Renowned Vaccinologists Stanley Plotkin and Anna Durbin to its Scientific Advisory Board

By: GlobenewsWire - 09 Dec 2019

Sanofi : Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion

By: GlobenewsWire - 09 Dec 2019

Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference

By: GlobenewsWire - 05 Dec 2019

Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK), one of the world's leading healthcare ecosystem platforms, signed a strategic collaboration agreement today with Merck, a leading science and technology... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

SHANGHAI, Dec. 4, 2019 /PRNewswire/ -- Merck, a leading science and technology company, signed a strategic collaboration agreement today with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor", 1833.HK).... Read more ››

By: PR Newswire Association LLC. - 04 Dec 2019

Related companies: HOOKIPA Pharma Inc.

Novo Nordisk A/S – Share repurchase programme

By: Nasdaq / GlobenewsWire - 25 Nov 2019

Sanofi: information concerning the total number of voting rights and shares, October 2019

By: Nasdaq / GlobenewsWire - 25 Nov 2019

Novo Nordisk expects to meet its current long-term financial targets and introduces strategic aspirations at the Capital Markets Day 2019

By: Nasdaq / GlobenewsWire - 20 Nov 2019

« 1 2 3 4 5 »

Looking for companies outside of Austria?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

January 2020
- Basel: R&D Data Intel Leaders Forum
- Nice: AgeingFIT
February 2020
- Zürich: Swiss Nordic Bio 2020

See Events »

Add an Event »

Latest company news

Sanofi : Sanofi Completes Acquisition of Synthorx, Inc.
23 Jan 2020 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
20 Jan 2020 (GlobenewsWire)

Sanofi: Disclosure of trading in own shares
20 Jan 2020 (GlobenewsWire)

News in the Life Sciences Industry

Valneva Completes Delisting from the Vienna Stock Exchange

Qu Biologics Completes Enrollment in First Stage of Phase 2 Clinical Trial in Moderate to Severe Crohn’s Disease

CMT's Manufacturing Automation Asia Summit draws Automotive, Aerospace, Pharma, Electronics, Chemical Manufacturers to Singapore

Novo Nordisk A/S – Share repurchase programme

Valneva Appoints MVM Partner Thomas Casdagli to its Supervisory Board

Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease

Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab)

Sanofi CEO unveils new strategy to drive innovation and growth

Novo Nordisk A/S – Share repurchase programme

Valneva Appoints Renowned Vaccinologists Stanley Plotkin and Anna Durbin to its Scientific Advisory Board

Sanofi : Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion

Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference

Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China

Merck and Ping An Good Doctor Form Strategic Collaboration to Advance Intelligent Healthcare in China

Novo Nordisk A/S - Share repurchase programme

Valneva Announces EMA Approval of IXIARO® Shelf Life Extension to 36 Months

HOOKIPA Pharma to Present at Piper Jaffray 31st Annual Healthcare Conference

Novo Nordisk A/S – Share repurchase programme

Sanofi: information concerning the total number of voting rights and shares, October 2019

Novo Nordisk expects to meet its current long-term financial targets and introduces strategic aspirations at the Capital Markets Day 2019

Looking for companies outside of Austria?

Partners

Upcoming Life Sciences Events

Latest company news